IQV - IQVIA Holdings Inc
IQVIA Holdings Inc Logo

IQV - IQVIA Holdings Inc

https://www.iqvia.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.

52W High
$248.03
52W Low
$134.65
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.32
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
27.16
Forward P/E (<15 better)
14.33
EV/EBITDA (<8 favorable)
13.56
EV/Revenue (<3 favorable)
2.89
P/S (TTM) (<3 favorable)
2.03
P/B (<3 favorable)
5.52
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
1.05%
Institutions (25–75% balanced)
102.15%
Shares Outstanding
170,000,000
Float
161,463,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
15,700,000,000
Gross Profit (TTM)
5,377,000,000
EPS (TTM)
6.91
Profit Margin (>10% good)
0.08%
Operating Margin (TTM) (higher better)
0.13%
ROE (TTM) (>15% strong)
0.20%
EPS YoY (Quarterly) (>10% good)
-0.22
Revenue YoY (Quarterly) (>8% good)
0.05
Momentum
Bearish momentum
Value
1.7765
Previous
1.6221
Trend
Rising
Signal Cross
No cross
As of
Sep. 09, 2025